Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Cash from Investing Activities (2023 - 2025)

Immunome's Cash from Investing Activities history spans 3 years, with the latest figure at -$4.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 140.98% year-over-year to -$4.0 million; the TTM value through Dec 2025 reached $60.8 million, up 171.48%, while the annual FY2025 figure was $60.8 million, 171.48% up from the prior year.
  • Cash from Investing Activities reached -$4.0 million in Q4 2025 per IMNM's latest filing, down from $123.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $123.9 million in Q3 2025 to a low of -$81.7 million in Q2 2024.
  • Average Cash from Investing Activities over 3 years is -$4.6 million, with a median of -$223000.0 recorded in 2023.
  • The largest YoY upside for Cash from Investing Activities was 67038.89% in 2024 against a maximum downside of 35023.58% in 2024.
  • A 3-year view of Cash from Investing Activities shows it stood at -$30.0 million in 2023, then soared by 132.52% to $9.8 million in 2024, then plummeted by 140.98% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for IMNM's Cash from Investing Activities are -$4.0 million (Q4 2025), $123.9 million (Q3 2025), and -$64.2 million (Q2 2025).